SKBR3 cells treated with epirubicin or hypoxia

GSE72362

Homo sapiens

11 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

Intratumoral heterogeneity may generate a diversity of resistance mechanisms that could cause different therapeutic responses in different cell populations.

PubMed ID

26340918

Publication Title

Breast cancer cells respond differentially to modulation of TGFβ2 signaling after exposure to chemotherapy or hypoxia.

Total Samples

Submitter’s Institution

Pfizer

Authors

O'Brien SK, Chen L, Zhong W, Armellino D, Yu J, Loreth C, Follettie M, Damelin M

Source Repository

Gene Expression Omnibus (GEO)

No rows found